Hikma Pharmaceuticals PLC is a publicly traded multinational pharmaceutical manufacturer that specializes in producing generic, specialty, and branded medicines for global markets. The company's core ... Hikma Pharmaceuticals PLC is a publicly traded multinational pharmaceutical manufacturer that specializes in producing generic, specialty, and branded medicines for global markets. The company's core business encompasses the development, manufacturing, and distribution of a diverse portfolio of pharmaceutical products, with an emphasis on non-branded generics and in-licensed medicines. Hikma operates across three primary segments: injectables, generics, and branded pharmaceuticals, with a significant portion of its revenue driven by the supply of generic injectables to hospitals, particularly in North America, which is its largest market. Additional operations span the Middle East and North Africa, the United Kingdom, and various European regions. Founded in 1978, Hikma has established a robust international presence, owning manufacturing plants and R&D centers in several countries. The firm’s strategic focus on expanding access to affordable medicines underscores its commitment to public health and its influential role as a leading supplier in key regions such as MENA and the US. Hikma’s position as a FTSE 100 constituent illustrates its relevance and stability within the global healthcare industry.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Hikma Pharmaceuticals is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Hikma Pharmaceuticals is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Hikma Pharmaceuticals's data?

Start your 30-day free trial to request a data review for Hikma Pharmaceuticals.

Start Free Trial

Legal Center Contact Us